Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trialJürgen Behr, Simone Hummler, Michael Kreuter et al.|The Lancet Respiratory Medicine|2021Cited by 523